| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3383317 | Reumatología Clínica | 2011 | 7 Pages |
Abstract
Based on the results of a theoretical decision-analytic model, the data obtained may suggest that tramadol/paracetamol is cost saving compared with NSAIDÂ +Â PPI for the treatment of OA pain over a period of 6Â months. Tramadol/paracetamol is also cost saving compared with treatment with NSAID alone if considering renal adverse events.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Javier Vidal, Pere Benito, Anna Manresa, Domingo Ly-Pen, Enrique Batlle, Francisco J. Blanco, Max Brosa, Diana Nieves,